LB
63
22
ORLY
62
2
ES
34
3
NRG
49
-3
KMI
67
-2
RHI
59
2
TGT
22
2
GPC
40
3
NSC
60
3
TJX
64
2
ACN
52
3
COF
60
2
IBM
58
-2
HST
49
-9
MCHP
41
4
WM
79
3
VFC
53
5
NVDA
56
-4
NDAQ
62
2
HSIC
56
5
LB
63
22
ORLY
62
2
ES
34
3
NRG
49
-3
KMI
67
-2
RHI
59
2
TGT
22
2
GPC
40
3
NSC
60
3
TJX
64
2
ACN
52
3
COF
60
2
IBM
58
-2
HST
49
-9
MCHP
41
4
WM
79
3
VFC
53
5
NVDA
56
-4
NDAQ
62
2
HSIC
56
5
Financhill
Back

Repligen Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48

RGEN
Repligen

Last Price:
142.62
Seasonality Move:
11.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Repligen Price Quote

$142.62
+0.04 (+0.61%)
(Updated: November 23, 2024 at 5:51 AM ET)

Repligen Key Stats

Sell
48
Repligen (RGEN) is a Sell
Day range:
$140.59 - $145.21
52-week range:
$113.50 - $211.13
Dividend yield:
0%
P/E ratio:
226.32
P/S ratio:
12.65
P/B ratio:
3.96%
Volume:
545.4K
Avg. volume:
688K
1-year change:
-11%
Market cap:
$8B
Revenue:
$632.4M
EPS:
$-0.31

How Much Does Repligen Make?

  • How Much Are Repligen's Sales Annually?
    RGEN Revenues are $632.4M
  • How Much Profit Does Repligen's Make A Year?
    RGEN net income is $35.6M

Is Repligen Growing As A Company?

  • What Is Repligen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Repligen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Repligen Stock Price Performance

  • Did Repligen Stock Go Up Last Month?
    Repligen share price went down by -1.08% last month
  • Did RGEN's Share Price Rise Over The Last Year?
    RGEN share price fell by -11% over the past 1 year

What Is Repligen 52-Week High & Low?

  • What Is Repligen’s 52-Week High Share Price?
    Repligen has traded as high as $211.13 over the past 52 weeks
  • What Is Repligen’s 52-Week Low Share Price?
    Repligen has traded as low as $113.50 over the past 52 weeks

Repligen Price To Free Cash Flow

  • Is Repligen Stock Overvalued?
    Repligen is trading at a price to free cash flow ratio of 61.05
  • Is Repligen Stock Undervalued?
    Repligen EV to Free Cash Flow ratio is 58.86
  • What Is Repligen’s Price Earnings Growth Ratio?
    RGEN PEG ratio is 0.00
  • Is Repligen Trading At A Premium To Earnings?
    Repligen EV to EBIT ratio is 257.68

Is It Risky To Buy Repligen?

  • How Much Debt Does Repligen Have?
    Total long term debt quarterly is $521.6M
  • How Much Cash Does Repligen Have?
    Cash and short term investments quarterly total is $784M
  • What Is Repligen’s Book Value Per Share?
    Book value per share is 36.00

Is Repligen Cash Flow Positive?

  • What Is RGEN Cash Flow From Operations?
    Cash flow from operations (TTM) is $165.3M
  • What Is Repligen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $183.8M
  • What Is Repligen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$191.5M

Repligen Return On Invested Capital

  • Is Management Doing A Good Job?
    RGEN return on invested capital is -0.32%
  • What Is Repligen Return On Assets?
    ROA measures how assets are converting to revenues and is -0.29%
  • What Is RGEN Return On Equity?
    ROE is a measure of profitability and is -0.41%

Repligen Earnings Date & Stock Price

  • What Is Repligen's Stock Price Today?
    A single share of RGEN can be purchased today for 142.58
  • What Is Repligen’s Stock Symbol?
    Repligen trades on the nasdaq under the ticker symbol: RGEN
  • When Is Repligen’s Next Earnings Date?
    The next quarterly earnings date for Repligen is scheduled on February 21, 2025
  • When Is RGEN's next ex-dividend date?
    Repligen's next ex-dividend date is November 23, 2024
  • How To Buy Repligen Stock?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Repligen Competitors

  • Who Are Repligen's Competitors?
    Below is a list of companies who compete with Repligen or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • QuidelOrtho Corp (QDEL)
    • Catheter Precision Inc (VTAK)
    • West Pharmaceutical Services Inc (WST)
    • Xtant Medical Holdings Inc (XTNT)

Repligen Dividend Yield

  • What Is RGEN Dividend Yield?
    Repligen’s dividend yield currently is 0%
  • What Is Repligen’s Payout Ratio?
    Repligen’s payout ratio is 0%
  • When Did Repligen Last Pay A Dividend?
    The latest dividend pay date is November 23, 2024
  • What Is Repligen’s Dividend Per Share?
    Repligen pays a dividend of $0.00 per share

Repligen Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 29.38%
Revenue: 9.69% 1.03%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 192.25
Upside from Last Price: 34.84%

Major Shareholders

  • How many RGEN shares are owned by institutional investors?
    91.8M RGEN shares are owned by institutional investors
  • How many RGEN shares are owned by insiders?
    2.5M RGEN shares are owned by insiders